Elite Diagnostic Limited (JMSE:ELITE)
Jamaica · Delayed Price · Currency is JMD 1.300
-0.010 (-0.76%)
At close: Aug 14, 2026
Elite Diagnostic Balance Sheet
Financials in millions JMD. Fiscal year is July - June.
Millions JMD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 124.17 | 225.55 | 37.22 | 53.88 | 75.89 |
Cash & Short-Term Investments | 124.17 | 225.55 | 37.22 | 53.88 | 75.89 |
Cash Growth | -44.95% | 505.98% | -30.92% | -29.00% | 18.59% |
Accounts Receivable | 91.23 | 80.34 | 139.03 | 113.62 | 55.88 |
Other Receivables | 3.81 | 4.91 | 3.3 | 2.86 | 3.38 |
Receivables | 95.04 | 85.25 | 142.34 | 116.49 | 59.26 |
Inventory | 15.59 | - | - | - | - |
Prepaid Expenses | 14.19 | 12.59 | 10.01 | 18.08 | 7.57 |
Other Current Assets | 21.78 | - | - | - | - |
Total Current Assets | 270.77 | 323.4 | 189.57 | 188.45 | 142.72 |
Property, Plant & Equipment | 1,023 | 767.15 | 840.24 | 883.46 | 773.84 |
Other Intangible Assets | - | 3.1 | 5.76 | 6 | 3 |
Other Long-Term Assets | 20.5 | 20.5 | 20.5 | 20.5 | - |
Total Assets | 1,314 | 1,114 | 1,056 | 1,098 | 919.56 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | - | 67.22 | 60.79 | 69.23 | 17.34 |
Accrued Expenses | - | 22.04 | 15.59 | - | 15.53 |
Short-Term Debt | 9.07 | 8.33 | 10.16 | 6.59 | 5.83 |
Current Portion of Long-Term Debt | 81.44 | 3.36 | 114.73 | 84.72 | 50.43 |
Current Portion of Leases | 35.28 | 30.9 | 30.01 | 26.58 | 8.69 |
Current Income Taxes Payable | - | 1.64 | 0.6 | 0.04 | - |
Other Current Liabilities | 56.46 | 1.8 | 11.03 | - | 6.48 |
Total Current Liabilities | 182.24 | 135.29 | 242.89 | 187.16 | 104.3 |
Long-Term Debt | 525.7 | 387.89 | 228.93 | 343.65 | 323.52 |
Long-Term Leases | 25.33 | 41.86 | 70.7 | 82.77 | 13.19 |
Long-Term Deferred Tax Liabilities | 6.1 | 6.1 | 2.56 | - | - |
Total Liabilities | 739.37 | 571.15 | 545.08 | 613.59 | 441.02 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 348.9 | 348.9 | 348.9 | 348.9 | 348.9 |
Retained Earnings | 225.61 | 194.11 | 162.08 | 135.93 | 129.65 |
Shareholders' Equity | 574.51 | 543.01 | 510.98 | 484.83 | 478.54 |
Total Liabilities & Equity | 1,314 | 1,114 | 1,056 | 1,098 | 919.56 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 676.81 | 472.33 | 454.52 | 544.32 | 401.66 |
Net Cash (Debt) | -552.64 | -246.78 | -417.3 | -490.44 | -325.77 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -1.58 | -0.70 | -1.18 | -1.39 | -0.92 |
Filing Date Shares Outstanding | 298.9 | 353.4 | 353.4 | 353.4 | 353.4 |
Total Common Shares Outstanding | 298.9 | 353.4 | 353.4 | 353.4 | 353.4 |
Working Capital | 88.53 | 188.1 | -53.33 | 1.29 | 38.42 |
Book Value Per Share | 1.92 | 1.54 | 1.45 | 1.37 | 1.35 |
Tangible Book Value | 574.51 | 539.9 | 505.22 | 478.82 | 475.54 |
Tangible Book Value Per Share | 1.92 | 1.53 | 1.43 | 1.35 | 1.35 |
Machinery | - | 1,278 | 1,187 | 1,118 | 1,045 |
Leasehold Improvements | - | 206.56 | 206.03 | 206.12 | 144.26 |